vs
IRIDEX CORP(IRIX)与KKR Real Estate Finance Trust Inc.(KREF)财务数据对比。点击上方公司名可切换其他公司
KKR Real Estate Finance Trust Inc.的季度营收约是IRIDEX CORP的1.8倍($25.8M vs $14.7M),KKR Real Estate Finance Trust Inc.同比增速更快(-26.6% vs -69.7%),过去两年IRIDEX CORP的营收复合增速更高(11.9% vs -18.8%)
IRIDEX Corporation是一家全球性医疗科技企业,主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备,产品供应至北美、欧洲、亚太等地区的医疗机构与诊所,为眼部疾病治疗和医美项目提供微创解决方案。
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台,主要发起、收购并管理优先担保商业地产贷款组合,抵押物多为美国各地的优质机构级商业地产,通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
IRIX vs KREF — 直观对比
营收规模更大
KREF
是对方的1.8倍
$14.7M
营收增速更快
KREF
高出43.2%
-69.7%
两年增速更快
IRIX
近两年复合增速
-18.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $14.7M | $25.8M |
| 净利润 | — | $-26.2M |
| 毛利率 | 37.2% | — |
| 营业利润率 | — | -105.1% |
| 净利率 | — | -101.7% |
| 营收同比 | -69.7% | -26.6% |
| 净利润同比 | — | -229.6% |
| 每股收益(稀释后) | — | $-0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IRIX
KREF
| Q4 25 | $14.7M | $25.8M | ||
| Q3 25 | $12.5M | $25.3M | ||
| Q2 25 | $13.6M | $30.2M | ||
| Q1 25 | $11.9M | $31.3M | ||
| Q4 24 | $12.7M | $35.1M | ||
| Q3 24 | $11.6M | $37.0M | ||
| Q2 24 | $12.6M | $40.4M | ||
| Q1 24 | $11.8M | $39.1M |
净利润
IRIX
KREF
| Q4 25 | — | $-26.2M | ||
| Q3 25 | $-1.6M | $13.8M | ||
| Q2 25 | $-994.0K | $-29.7M | ||
| Q1 25 | $-1.7M | $-4.9M | ||
| Q4 24 | $-834.0K | $20.3M | ||
| Q3 24 | $-1.9M | $-7.4M | ||
| Q2 24 | $-2.7M | $25.8M | ||
| Q1 24 | $-3.5M | $-3.1M |
毛利率
IRIX
KREF
| Q4 25 | 37.2% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 34.5% | — | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | 44.0% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | 37.9% | — |
营业利润率
IRIX
KREF
| Q4 25 | — | -105.1% | ||
| Q3 25 | -11.3% | 50.4% | ||
| Q2 25 | -6.9% | -101.3% | ||
| Q1 25 | -1.7% | -18.3% | ||
| Q4 24 | -3.9% | 55.8% | ||
| Q3 24 | -16.1% | -19.6% | ||
| Q2 24 | -20.9% | 63.3% | ||
| Q1 24 | -28.0% | -8.7% |
净利率
IRIX
KREF
| Q4 25 | — | -101.7% | ||
| Q3 25 | -12.6% | 54.4% | ||
| Q2 25 | -7.3% | -98.5% | ||
| Q1 25 | -14.2% | -15.5% | ||
| Q4 24 | -6.6% | 57.7% | ||
| Q3 24 | -16.7% | -20.0% | ||
| Q2 24 | -21.2% | 63.9% | ||
| Q1 24 | -29.5% | -7.9% |
每股收益(稀释后)
IRIX
KREF
| Q4 25 | — | $-0.49 | ||
| Q3 25 | $-0.09 | $0.12 | ||
| Q2 25 | $-0.06 | $-0.53 | ||
| Q1 25 | $-0.10 | $-0.15 | ||
| Q4 24 | $-0.05 | $0.22 | ||
| Q3 24 | $-0.12 | $-0.19 | ||
| Q2 24 | $-0.16 | $0.29 | ||
| Q1 24 | $-0.21 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $6.0M | $84.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $1.2B |
| 总资产 | $29.2M | $6.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
IRIX
KREF
| Q4 25 | $6.0M | $84.6M | ||
| Q3 25 | $5.6M | $204.1M | ||
| Q2 25 | $6.8M | $107.7M | ||
| Q1 25 | $7.2M | $106.4M | ||
| Q4 24 | $2.4M | $104.9M | ||
| Q3 24 | $3.9M | $108.8M | ||
| Q2 24 | $4.1M | $107.2M | ||
| Q1 24 | $5.4M | $106.5M |
总债务
IRIX
KREF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.0M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
IRIX
KREF
| Q4 25 | — | $1.2B | ||
| Q3 25 | $4.7M | $1.2B | ||
| Q2 25 | $6.1M | $1.2B | ||
| Q1 25 | $852.0K | $1.3B | ||
| Q4 24 | $2.1M | $1.3B | ||
| Q3 24 | $2.6M | $1.4B | ||
| Q2 24 | $4.2M | $1.4B | ||
| Q1 24 | $6.5M | $1.4B |
总资产
IRIX
KREF
| Q4 25 | $29.2M | $6.5B | ||
| Q3 25 | $28.4M | $6.5B | ||
| Q2 25 | $31.6M | $6.8B | ||
| Q1 25 | $34.2M | $6.6B | ||
| Q4 24 | $29.1M | $6.4B | ||
| Q3 24 | $30.2M | $6.8B | ||
| Q2 24 | $31.2M | $7.1B | ||
| Q1 24 | $34.1M | $7.3B |
负债/权益比
IRIX
KREF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $72.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
IRIX
KREF
| Q4 25 | — | $72.3M | ||
| Q3 25 | $-1.2M | $18.5M | ||
| Q2 25 | $-397.0K | $21.1M | ||
| Q1 25 | $-1.1M | $15.9M | ||
| Q4 24 | $-1.2M | $132.6M | ||
| Q3 24 | $-3.1M | $49.1M | ||
| Q2 24 | $-1.3M | $30.6M | ||
| Q1 24 | $-1.6M | $34.5M |
自由现金流
IRIX
KREF
| Q4 25 | — | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $-410.0K | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-3.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-1.7M | — |
自由现金流率
IRIX
KREF
| Q4 25 | — | — | ||
| Q3 25 | -9.4% | — | ||
| Q2 25 | -3.0% | — | ||
| Q1 25 | -9.8% | — | ||
| Q4 24 | -9.8% | — | ||
| Q3 24 | -26.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -14.0% | — |
资本支出强度
IRIX
KREF
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率
IRIX
KREF
| Q4 25 | — | — | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.19× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图